Please use this identifier to cite or link to this item:
https://doi.org/10.1056/NEJMoa020681
DC Field | Value | |
---|---|---|
dc.title | Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B | |
dc.contributor.author | Marcellin, P. | |
dc.contributor.author | Chang, T.-T. | |
dc.contributor.author | Lim, S.G. | |
dc.contributor.author | Tong, M.J. | |
dc.contributor.author | Sievert, W. | |
dc.contributor.author | Shiffman, M.L. | |
dc.contributor.author | Jeffers, L. | |
dc.contributor.author | Goodman, Z. | |
dc.contributor.author | Wulfsohn, M.S. | |
dc.contributor.author | Xiong, S. | |
dc.contributor.author | Fry, J. | |
dc.contributor.author | Brosgart, C.L. | |
dc.date.accessioned | 2014-12-17T08:54:16Z | |
dc.date.available | 2014-12-17T08:54:16Z | |
dc.date.issued | 2003 | |
dc.identifier.citation | Marcellin, P., Chang, T.-T., Lim, S.G., Tong, M.J., Sievert, W., Shiffman, M.L., Jeffers, L., Goodman, Z., Wulfsohn, M.S., Xiong, S., Fry, J., Brosgart, C.L. (2003). Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B. New England Journal of Medicine 348 (9) : 808-816. ScholarBank@NUS Repository. https://doi.org/10.1056/NEJMoa020681 | |
dc.identifier.issn | 00284793 | |
dc.identifier.uri | http://scholarbank.nus.edu.sg/handle/10635/117545 | |
dc.description.uri | http://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.1056/NEJMoa020681 | |
dc.source | Scopus | |
dc.type | Article | |
dc.contributor.department | MEDICINE | |
dc.description.doi | 10.1056/NEJMoa020681 | |
dc.description.sourcetitle | New England Journal of Medicine | |
dc.description.volume | 348 | |
dc.description.issue | 9 | |
dc.description.page | 808-816 | |
dc.description.coden | NEJMA | |
dc.identifier.isiut | 000181173300007 | |
Appears in Collections: | Staff Publications |
Show simple item record
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.